These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33683196)

  • 41. Salvage of severe recurrent Dupuytren's contracture of the ring and small fingers.
    Watson HK; Lovallo JL
    J Hand Surg Am; 1987 Mar; 12(2):287-9. PubMed ID: 3559089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of Dupuytren's contracture by means of injectable collagenase: first clinical experiences].
    Spanholtz TA; Holzbach T; Wallmichrath J; Pototschnig A; Deglmann C; Frick A; Giunta RE
    Handchir Mikrochir Plast Chir; 2011 Oct; 43(5):275-80. PubMed ID: 21935844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Surgical Release of Dupuytren's Contracture Using Multiple Transverse Incisions.
    Lee H; Eo S; Cho S; Jones NF
    Arch Plast Surg; 2012 Jul; 39(4):426-30. PubMed ID: 22872850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Minimally invasive treatment of Dupuytren's contracture by Pi needle percutaneous multi-segmental fasciotomy].
    Chen XH; Wang XX
    Zhongguo Gu Shang; 2018 Jun; 31(6):514-517. PubMed ID: 29945405
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin as an adjunct for severe Dupuytren's contracture treated with collagenase injections.
    Denkler KA; Cheng J; Song S; Hansen S
    Arch Clin Cases; 2022; 9(4):133-135. PubMed ID: 36628168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term efficacy and safety of collagenase injection for Dupuytren's contracture: Therapy protocol for successful outcomes in a clinical setting.
    Sakai A; Zenke Y; Menuki K; Yamanaka Y; Tajima T; Tsukamoto M; Uchida S
    J Orthop Sci; 2019 May; 24(3):434-440. PubMed ID: 30392714
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pilot study assessing the effectiveness of postoperative splinting after limited fasciectomy for Dupuytren's disease.
    Kemler MA; Houpt P; van der Horst CM
    J Hand Surg Eur Vol; 2012 Oct; 37(8):733-7. PubMed ID: 22311918
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular Complication after Collagenase Injection and Manipulation for Dupuytren's Contracture: A Case Report.
    Kawano Y; Hagiwara T; Tanaka N; Nakamura T; Takeda H; Itabashi T; Furukawa M; Kikuchi K; Okuyama K
    JMA J; 2019 Sep; 2(2):196-199. PubMed ID: 33615032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease.
    Misra A; Jain A; Ghazanfar R; Johnston T; Nanchahal J
    J Hand Surg Am; 2007 Feb; 32(2):240-5. PubMed ID: 17275601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
    Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
    Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central slip attenuation in Dupuytren's contracture: a cause of persistent flexion of the proximal interphalangeal joint.
    Smith P; Breed C
    J Hand Surg Am; 1994 Sep; 19(5):840-3. PubMed ID: 7806815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Injectable collagenase Clostridium histolyticum as a nonsurgical treatment for Dupuytren's disease.
    Arora R; Kaiser P; Kastenberger TJ; Schmiedle G; Erhart S; Gabl M
    Oper Orthop Traumatol; 2016 Feb; 28(1):30-7. PubMed ID: 26683416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors predicting the 1-year outcome of collagenase treatment for Dupuytren's disease.
    Scheibler AG; Marks M; Hensler S; Herren DB; Calcagni M
    Arch Orthop Trauma Surg; 2019 Apr; 139(4):583-588. PubMed ID: 30673868
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dupuytren's disease: outcome of the proximal interphalangeal joint in isolated fifth ray involvement.
    Van Giffen N; Degreef I; De Smet L
    Acta Orthop Belg; 2006 Dec; 72(6):671-7. PubMed ID: 17260603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Dupuytren's disease. State of the art and therapeutic perspectives].
    Corrado A; Cantatore FP
    Reumatismo; 2007; 59(2):118-28. PubMed ID: 17603691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of Dupuytren's disease with collagenase injections in Germany: efficacy and adverse effects in 110 treated joints].
    Pototschnig A; Volkmer E; Giunta RE
    Handchir Mikrochir Plast Chir; 2017 Aug; 49(3):154-161. PubMed ID: 28806826
    [No Abstract]   [Full Text] [Related]  

  • 57. Severe contracture of the proximal interphalangeal joint in Dupuytren's disease: does capsuloligamentous release improve outcome?
    Beyermann K; Prommersberger KJ; Jacobs C; Lanz UB
    J Hand Surg Br; 2004 Jun; 29(3):240-3. PubMed ID: 15142694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complications following surgical treatment for Dupuytren's contracture.
    Prosser R; Conolly WB
    J Hand Ther; 1996; 9(4):344-8. PubMed ID: 8994009
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative Effectiveness of Percutaneous Needle Aponeurotomy and Limited Fasciectomy for Dupuytren's Contracture: A Multicenter Observational Study.
    Zhou C; Selles RW; Slijper HP; Feitz R; van Kooij Y; Moojen TM; Hovius SER
    Plast Reconstr Surg; 2016 Oct; 138(4):837-846. PubMed ID: 27307334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Enzyme injection as nonsurgical treatment of Dupuytren's disease.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2000 Jul; 25(4):629-36. PubMed ID: 10913202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.